Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jun;70(6):549-55.
doi: 10.1136/jech-2015-206629. Epub 2015 Dec 23.

CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

Anna Grimsrud  1 , Morna Cornell  2 , Michael Schomaker  3 , Matthew P Fox  4 , Catherine Orrell  5 , Hans Prozesky  6 , Kathryn Stinson  7 , Frank Tanser  8 , Matthias Egger  9 , Landon Myer  2 ; International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration (IeDEA-SA)
Affiliations
Multicenter Study

CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

Anna Grimsrud et al. J Epidemiol Community Health. 2016 Jun.

Abstract

Background: Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. However data on the relationship between CD4 count at ART initiation and loss to follow-up (LTFU) are limited and conflicting.

Methods: We conducted a cohort analysis including all adults initiating ART (2008-2012) at three public sector sites in South Africa. LTFU was defined as no visit in the 6 months before database closure. The Kaplan-Meier estimator and Cox's proportional hazards models examined the relationship between CD4 count at ART initiation and 24-month LTFU. Final models were adjusted for demographics, year of ART initiation, programme expansion and corrected for unascertained mortality.

Results: Among 17 038 patients, the median CD4 at initiation increased from 119 (IQR 54-180) in 2008 to 257 (IQR 175-318) in 2012. In unadjusted models, observed LTFU was associated with both CD4 counts <100 cells/μL and CD4 counts ≥300 cells/μL. After adjustment, patients with CD4 counts ≥300 cells/μL were 1.35 (95% CI 1.12 to 1.63) times as likely to be LTFU after 24 months compared to those with a CD4 150-199 cells/μL. This increased risk for patients with CD4 counts ≥300 cells/μL was largest in the first 3 months on treatment. Correction for unascertained deaths attenuated the association between CD4 counts <100 cells/μL and LTFU while the association between CD4 counts ≥300 cells/μL and LTFU persisted.

Conclusions: Patients initiating ART at higher CD4 counts may be at increased risk for LTFU. With programmes initiating patients at higher CD4 counts, models of ART delivery need to be reoriented to support long-term retention.

Keywords: EPIDEMIOLOGY; HIV; INTERNATIONAL HLTH; LONGITUDINAL STUDIES.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier plots showing observed and corrected 24 months loss to follow-up (LTFU) by CD4 count at ART initiation. (A) Observed LTFU by CD4 count at antiretroviral therapy (ART) initiation 0–24 months follow-up. (B) Corrected LTFU by CD4 count at ART initiation 0–24 months follow-up.
Figure 2
Figure 2
Corrected loss to follow-up from Kaplan-Meier estimates by CD4 count at antiretroviral therapy initiation.
Figure 3
Figure 3
Adjusted 12-months log hazard ratios of observed and corrected loss to follow-up from Cox's proportional hazards models by CD4 count at antiretroviral therapy (ART) initiation. Adjusted for year of ART initiation, gender, age, programme size and rate of expansion.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. UNAIDS. The gap report. Geneva: UNAIDS; 2014.
    1. World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. Geneva: World Health Organization; 2013.
    1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision) Geneva: World Health Organization; 2006. - PubMed
    1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: World Health Organization; 2010. - PubMed
    1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013. - PubMed

Publication types

Substances